$VRTX Company News Oracle falls on earnings, E
Post# of 72749

Oracle falls on earnings, Ellison move; Alibaba soars on debut 4:08 p.m. Sept. 19, 2014 - Sue Chang
Vertex Pharmaceuticals shares jump 4.9%, pace S&P 500 advancers 9:59 a.m. Sept. 5, 2014 - Tomi Kilgore
U.S. stocks push higher; biotechs rally 4:06 p.m. Aug. 13, 2014 - Anora Mahmudova
Vertex leads S&P 500, King drops on outlook 3:55 p.m. Aug. 13, 2014 - Sue Chang
10 stocks suffering the biggest cuts in earnings estimates 1:39 p.m. Aug. 11, 2014 - Philip van Doorn
Kinder Morgan soars, Tesla rallies on upgrade 12:46 p.m. Aug. 11, 2014 - Sue Chang
Mobileye rises for second day; Michael Kors falls 1:23 p.m. Aug. 4, 2014 - Sue Chang
Charting a slow-motion breakout attempt 11:08 a.m. July 23, 2014 - Michael Ashbaugh
U.S. stocks fall; Dow in triple-digit loss 4:36 p.m. June 24, 2014 - Anora Mahmudova
Dow falls over 100 points; energy stocks sell off: Stock market live blog recap 3:46 p.m. June 24, 2014 - blogs.marketwatch.com
Vertex soars on trial success; Best Buy gets buy rating 3:30 p.m. June 24, 2014 - Sue Chang
New studies bode well for Vertex's cystic fibrosis drug, analysts say 1:32 p.m. June 24, 2014 - Russ Britt
Vertex Pharmaceuticals shares skyrocket 50% 9:33 a.m. June 24, 2014 - Sue Chang
Vertex’ late-stage Cystic Fibrosis trial meets goals 7:59 a.m. June 24, 2014 - Anna Prior
Vertex Pharmaceuticals soars 46% on treatment trial 7:32 a.m. June 24, 2014 - Ben Eisen
Vertex reports successful Phase 3 trial of cystic fibrosis treatment 7:23 a.m. June 24, 2014 - Ciara Linnane
Vertex reports successl Phase 3 trial of cystic fibrosis treatment 7:12 a.m. June 24, 2014 - Ciara Linnane
E-Trade, Schwab up on HFT hearing; Tesla extends gains 3:54 p.m. June 17, 2014 - Sue Chang
Covidien surges on sale; Yahoo drops on Alibaba results 3:48 p.m. June 16, 2014 - Sue Chang
Charting the approach of S&P 2,000 12:28 p.m. June 10, 2014 - Michael Ashbaugh
Biggest Movers in Healthcare Stocks Now – ANAC CLDX VRTX EXAS 7:45 a.m. Sept. 19, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – VRTX IRWD NBIX ACOR 1:15 p.m. Sept. 18, 2014 - InvestorPlace.com
Stock Market News for September 16, 2014 - Market News 10:10 a.m. Sept. 16, 2014 - Zacks.com
3 Hot Ways to Play the Biotechnology Bonanza 6:36 a.m. Sept. 16, 2014 - InvestorPlace.com
Uncertainty Prevails For Vertex 3:48 p.m. Sept. 11, 2014 - Seeking Alpha
3 Stocks Underperforming Today In The Health Care Sector 1:04 p.m. Sept. 9, 2014 - TheStreet.com
Stock Market News for September 08, 2014 - Market News 10:10 a.m. Sept. 8, 2014 - Zacks.com
Goldman Sachs Upgrades Vertex Pharmaceuticals To Buy 6:59 a.m. Sept. 8, 2014 - benzinga.com
Vertex Pharmaceuticals (VRTX) Is Today's Strong On High Volume Stock 10:01 a.m. Sept. 5, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – VRTX HCA BLUE CYH 8:30 a.m. Sept. 5, 2014 - InvestorPlace.com
Analysts' Actions: Ciena, Finisar, Vertex and More 8:16 a.m. Sept. 5, 2014 - TheStreet.com
Top Analyst Upgrades and Downgrades: BP, Ciena, Finisar, SanDisk, VeriFone, Vertex, Wynn and More 7:37 a.m. Sept. 5, 2014 - 247WallSt.com
Stock Market News for August 26, 2014 - Market News 10:10 a.m. Aug. 26, 2014 - Zacks.com
Biggest Movers in Healthcare Stocks Now – PBYI TRNX KERX NBIX 1:15 p.m. Aug. 22, 2014 - InvestorPlace.com
3 Drugs Stocks Dragging The Industry Down 1:04 p.m. Aug. 21, 2014 - TheStreet.com
Biotech Stock Roundup: Achillion Scores in Mid-Stage Study, Gilead's Sovaldi Remains in Focus - Analyst Blog 11:08 a.m. Aug. 20, 2014 - Zacks.com
Biotech, Social Media Stocks Are Less Frothy Than Janet Yellen Thinks 12:34 p.m. Aug. 14, 2014 - TheStreet.com
Stock Market News for August 14, 2014 - Market News 10:10 a.m. Aug. 14, 2014 - Zacks.com
Stock Market Today: Equities Rally Despite Poor Retail Earnings - Stocks in the News 4:44 p.m. Aug. 13, 2014 - Zacks.com
Hottest Healthcare Stocks Now – VRTX LCI ENDP CBPO 8:15 a.m. Aug. 13, 2014 - InvestorPlace.com
Analyst Scanner on Biotech Equities - Prana Biotechnology, CytRx, Insmed, Dynavax Technologies, and Vertex Pharma 9:15 a.m. Sept. 11, 2014 - PR Newswire - PRF
Market Activity, Drug Approval, Upcoming Conference, and Presentation of Clinical Data - Research Reports on Jazz, Keryx, Vertex, WellPoint and GSK 9:15 a.m. Sept. 10, 2014 - PR Newswire - PRF
Global Hepatitis C Market 2014-2018 9:58 p.m. Sept. 8, 2014 - PR Newswire - PRF
Vertex Announces Upcoming Presentations of Data at North American Cystic Fibrosis Conference - October 9 to 11, 2014 9:03 a.m. Sept. 8, 2014 - BusinessWire - BZX
Vertex to Present at the Morgan Stanley Global Healthcare Conference on September 10 4:01 p.m. Sept. 2, 2014 - BusinessWire - BZX
Upcoming Conferences, Market Activity, Drug Approval, and Earnings Release - Research Reports on Mallinckrodt, Vertex Pharmaceuticals, Kite, Bristol-Myers Squibb and Arrowhead 8:40 a.m. Aug. 29, 2014 - PR Newswire - PRF
Critical Alerts For GoPro, Intercept Pharmaceuticals, Pixelworks, Vertex Pharmaceuticals and General Mills. Released By InvestorsObserver 9:31 a.m. Aug. 13, 2014 - PR Newswire - PRF
Cannabis Should Be Treated as an Agricultural Commodity, Not a Biotech Investment 2:44 p.m. Aug. 11, 2014 - ACCESSWIRE
New Joint Ventures, Course Launches, Study Results, Earnings Performance, and Approvals - Research Reports on Johnson Controls, Intuitive Surgical, GlaxoSmithKline, Community Health and Vertex 8:50 a.m. Aug. 6, 2014 - PR Newswire - PRF
Biotech Equities Roundup -- Keryx Biopharma, Vertex Pharma, NPS Pharma, Cubist Pharma, and Idera Pharma 8:50 a.m. Aug. 6, 2014 - PR Newswire - PRF
Vertex Receives European Approval for KALYDECO™ (ivacaftor) in Eight Non-G551D Gating Mutations 4:18 p.m. July 31, 2014 - BusinessWire - BZX
MONDAY DEADLINE: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Vertex Pharmaceuticals Incorporated and Its Board of Directors and a Lead Plaintiff Deadline of July 28, 2014 -- VRTX 6:56 p.m. July 25, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Brower Piven Encourages Investors With Losses Over $100,000 In Vertex Pharmaceuticals Incorporated To Contact The Firm Before The Lead Plaintiff Deadline In Class Action Lawsuit -- VRTX 5:44 p.m. July 22, 2014 - GlobeNewswire
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Vertex Pharmaceuticals Incorporated and Its Board of Directors and a Lead Plaintiff Deadline of July 28, 2014 -- VRTX 1:33 p.m. July 15, 2014 - GlobeNewswire
Vertex to Announce Second Quarter 2014 Financial Results on July 29 4:01 p.m. July 14, 2014 - BusinessWire - BZX
Vertex Announces Retirement of Peter Mueller, Ph.D. 8:02 a.m. July 10, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action against Vertex Pharmaceuticals Incorporated and Its Board of Directors and a Lead Plaintiff Deadline of July 28, 2014 6:11 p.m. July 7, 2014 - BusinessWire - BZX
Agreements, NDA Submissions, FDA Approvals, Enrollment Updates, and Index Inclusions - Analyst Notes on Jazz Pharmaceuticals, Vertex, NPS, StemCells and Achillion 5:50 a.m. July 7, 2014 - PR Newswire - PRF
Vertex Submits Supplemental New Drug Application (sNDA) to U.S. Food and Drug Administration for Use of KALYDECO® (ivacaftor) in People 18 and Older with Cystic Fibrosis who have the R117H Mutation 4:05 p.m. June 30, 2014 - BusinessWire - BZX
Scheduled Conference Calls, License Agreements, Dividends, Preliminary Proxy statements and Initiation of Clinical Studies - Analyst Notes on Merck, Johnson & Johnson, AbbVie, Valeant and GSK 5:20 a.m. June 30, 2014 - PR Newswire - PRF

